Opus Point Partners Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,414	Closed	-$527K	–	62
2017 Q2	$527K	Sell	20,414 -70	-0.3%	-$1.81K	0.48%	39
2017 Q1	$393K	Buy	20,484 +6,577	+47%	+$126K	0.29%	49
2016 Q4	$232K	Buy	+13,907	New	+$232K	0.18%	51